Régorafénib (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Régorafénib" in French language version.

refsWebsite

Global rank French rank

2,393^rd place

506^th place

447^th place

1,409^th place

68^th place

67^th place

222^nd place

129^th place

europa.eu

ema.europa.eu

Communiqué de l'Agence Européenne du Médicament, 27 juin 2013

fda.gov

fda.gov

FDA approves new treatment for advanced colorectal cancer, 27 Sep 2012

accessdata.fda.gov

FDA Prescribing Information

thelancet.com

Grothey A, Van Cutsem E, Sobrero A et al. for the CORRECT Study Group. |Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial, Lancet, 2013;381:303-312
Demetri GD, Reichardt P, Kang Y-K et al. on behalf of all GRID study investigators. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial, Lancet, 2013;381:295-302
Bruix J, Quin S, Merle P et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet,2017;389:56–66
Waddell T, Cunningham D, Evaluation of regorafenib in colorectal cancer and GIST, Lancet, 2013;381:273-275

wiley.com

onlinelibrary.wiley.com

Wilhelm SM, Dumas J, Adnane L et al. Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity, Int J Cancer, 2011;129:245-255